Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endoscopic Ultrasound Guided Radio Frequency Ablation of Pancreatic Neuroendocrine Neoplasms

NCT05243082 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT05243082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05243082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endoscopic Ultrasound Guided Radio Frequency Ablation of Pancreatic Neuroendocrine Neoplasms
Lead sponsor
Oslo University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
January 14, 2022
Completion date
November 11, 2029
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic neuroendocrine tumors, who grade i-ii